COVID-19 and Cancer: Screenings Rebound but Study Finds Disparities
Cancer screenings rebounded after a dramatic decline in the first months of the COVID-19 pandemic, but a new study found an increase in disparities among some screening tests during the pandemic. Dana-Farber Cancer Institute's Toni Choueiri, MD, and Chris Labaki, MD, detail the findings. Press Release: http://ms.spr.ly/6053nN0Fd
Dr. Toni K. Choueiri is the Director of the Lank Center for Genitourinary (GU) Oncology at Dana-Farber Cancer Institute, co-leader of the Kidney Cancer Program at Dana-Farber/Harvard Cancer Center, and the Jerome and Nancy Kohlberg Chair ...
